Search results
Researchers at UF Health in Gainesville are one step closer to finding a cure for cancer
First Coast News· 2 days agoResearchers at UF Health in Gainesville are making one of the biggest discoveries in cancer research...
Billionaire Jim Simons Owns These 2 Healthcare Stocks: Should You?
Motley Fool via Yahoo Finance· 4 days agoIts two most important markets are renal cell carcinoma (RCC, a type of kidney cancer) and...
Blood draw cancer detection test in clinical trials at OU Stephenson Cancer Center
KFOR articles via Yahoo News· 3 days agoA simple blood draw may be able to detect over 50 types of cancer. It’s called a “multi-cancer early...
MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim...
Morningstar· 6 days agoPresentation of interim TAMARACK Phase 2 study data: updated safety and preliminary efficacy of vobra duo in mCRPC patientsConference call scheduled for today at 4:30 p.m. ET ROCKVILLE, Md., May 09, 2024 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ
AI advancements make the leap into 3D pathology possible
Medical Xpress· 7 days agoIn a new study, researchers from Mass General Brigham and their collaborators present Tripath: new, deep learning models that can use 3D pathology datasets to make clinical outcome predictions ...
New research and treatment advances from Yale Canc | Newswise
Newswise· 3 days agoNearly 50 presentations by researchers and clinicians from Yale Cancer Center (YCC) at Yale School of Medicine will be among the more than 5,000 abstracts
Caris Life Sciences to Showcase Extensive Research Highlighting the Clinical Value of Comprehensive...
FOX 5 San Diego· 2 days agoCaris Life Sciences® (Caris), the leading next-generation AI TechBio company and precision medicine pioneer, today announced that the company and collaborators from the biopharma industry and ...
New Research and Treatment Advances From Yale Canc | Newswise
Newswise· 3 days agoNearly 50 presentations by researchers and clinicians from Yale Cancer Center (YCC) at Yale School of Medicine will be among the more than 5,000 abstracts
Earnings call: INmune Bio optimistic on XPro and INKmune trials progress By Investing.com
Investing.com· 3 days agoINmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology company, reported its first-quarter...
BioNTech (NASDAQ:BNTX) Coverage Initiated by Analysts at Evercore ISI
ETF DAILY NEWS· 1 day agoEvercore ISI assumed coverage on shares of BioNTech (NASDAQ:BNTX – Free Report) in a research note issued to investors on Tuesday, Marketbeat reports. TD Cowen boosted their price objective ...